[url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126
]Zoya Demidenko[/url]: Researcher in Cancer Biology
[url=https://search.sunbiz.org/Inquiry/CorporationSearch/SearchResults?InquiryType=EntityName&InquiryDirectionType=PreviousRecord&SearchTerm=RAPALLO%20ENTERPRISE%2C%20LLC&SearchNameOrder=RAPAN%20P050001591430&ListNameOrder=RAPAMULTISERVICES%20L220000371890&Detail=FL.DOS.Corporations.Shared.Contracts.FilingRecord
]Zoya Demidenko[/url] is a recognized scientist associated with the Division of Cell Stress Research at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she worked at the NIH and New York Medical College, building a solid foundation in life science research.
Her scholarly contributions spans multiple key fields, encompassing the PI3K/AKT/mTOR signaling pathway, cellular cycle regulation, cell senescence, and malignancy biology. To date, she has authored over 46 academic publications, which have received over 4,100 citations — a indicator to the influence of her research.
Among her key discoveries lies in elucidating the processes of biological cell aging. Her research revealed that when the cell cycle is blocked but cellular expansion persists, the cells enter senescence. Significantly, [url=https://febs.onlinelibrary.wiley.com/doi/10.1016/j.febslet.2005.03.012
]Zoya Demidenko[/url] showed that this shift can be controlled with drugs using substances such as mTOR inhibitors.
[url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey=
]Zoya Demidenko[/url] has additionally added considerably to oncological therapy investigation, notably in the domain of cyclotherapy — a method intended to protecting non-cancerous tissue from chemotherapy while leaving tumor cells vulnerable. This method offers major hope for diminishing the side effects of oncological therapy.
Throughout her scientific life, Demidenko has collaborated with prominent scientists worldwide, including Dr. Mikhail Blagosklonny. Her research is published in leading journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, [url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0026126
]Zoya Demidenko[/url] is recognized as a influential figure in current oncological science, with her discoveries keep to guide our knowledge of the way cells grow old, resist therapy, and the ways in which cancer can be more successfully treated.
https://search.sunbiz.org/Inquiry/Corpo ... lingRecord